MORRISVILLE, N.C., Sept. 25, 2023 (GLOBE NEWSWIRE) — Liquidia Corporation (the Company) (NASDAQ: LQDA) announced today that the U.S. Food and Drug Administration (FDA) accepted for review the Company’s amendment to the tentatively approved…Original Article
FDA Accepts Submission to Add PH-ILD to Yutrepia™ Label
